EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

Artificial Intelligence for Breast Cancer Molecular Subtype Prediction From Medical Imaging: A Systematic Review of Literature

Juan Camilo Morales-Duran iD, Kevin Osorno-Castillo iD, Gloria M Díaz iD

Technology in Cancer Research & Treatment · 2026-07 · 25

DOI: 10.1177/15330338261465062 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Technology in Cancer Research & Treatment, online erschienen am 25.07.2026. Verfasst von Juan Camilo Morales-Duran und 2 weiteren Autor:innen. Beteiligte Einrichtung: Grupo de Investigación Máquinas Inteligentes y Reconocimiento de Patrones, Facultad de Ingenierías, Institución Universitaria ITM, Medellín, Colombia. Hauptthemen laut MEDLINE: Artificial Intelligence, Breast Neoplasms, Diagnostic Imaging, Image Processing, Computer-Assisted. Die Arbeit nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Institucion Universitaria ITM.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer molecular subtypes (Luminal A, luminal B, HER2-positive, and triple-negative) are typically determined through biopsy and immunohistochemistry, procedures that are invasive and prone to interpretative variability. Artificial intelligence applied to medical imaging has emerged as a non-invasive alternative to support subtype prediction. However, methodological rigor, risk of bias and clinical translatability of existing studies remain insufficiently characterized.

Methods

We conducted a systematic review in accordance with the PRISMA 2020 guidelines. Searches were performed in Scopus, Web of Science, ScienceDirect, and PubMed to identify English-language, peer-reviewed original articles published between January 1, 2020, and March 25, 2025. Two reviewers independently screened titles and abstracts using Rayyan, retrieved potentially eligible full-text articles, and assessed risk of bias and applicability using an AI-adapted QUADAS framework based on QUADAS-2.

Results

From 626 identified records, 76 full-text articles were assessed for eligibility. The AI-adapted QUADAS framework showed that 67 of these 76 articles were excluded because they presented a high or unclear risk of bias in at least one evaluated domain. Consequently, only 9 studies were judged to have a low risk of bias and were included in the qualitative synthesis. The included evidence was dominated by studies using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), with additional contributions from ultrasound-based approaches. The methodological strategies ranged from radiomics-based machine learning models to deep learning architectures.

Discussion

Integrating radiomic signatures with clinical predictors may improve performance in selected clinical scenarios, and peri-tumoral information alongside delayed DCE-MRI phases can contribute complementary diagnostic value. Nevertheless, the small number of low-risk studies highlights the need for standardized acquisition and preprocessing reporting, patient-level data splitting, robust external validation, and broader data availability to strengthen the clinical translation and generalizability of AI-based molecular subtyping.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceBreast NeoplasmsDiagnostic ImagingImage Processing, Computer-AssistedFemaleHumansBiomarkers, Tumor

Stichwörter der Autor:innen

QUADASartificial intelligencebreast cancermedical imagingmolecular subtype

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Grupo de Investigación Máquinas Inteligentes y Reconocimiento de Patrones, Facultad de Ingenierías, Institución Universitaria ITM, Medellín, Colombia.

ORCID-Profile: Juan Camilo Morales-Duran, Kevin Osorno-Castillo, Gloria M Díaz

Förderung

  • Institucion Universitaria ITM

Zitieren

APA

Morales-Duran, J. C., Osorno-Castillo, K., & Díaz, G. M. (2026). Artificial Intelligence for Breast Cancer Molecular Subtype Prediction From Medical Imaging: A Systematic Review of Literature. Technology in Cancer Research & Treatment, 25. https://doi.org/10.1177/15330338261465062

Vancouver

Morales-Duran JC, Osorno-Castillo K, Díaz GM. Artificial Intelligence for Breast Cancer Molecular Subtype Prediction From Medical Imaging: A Systematic Review of Literature. Technology in Cancer Research & Treatment. 2026;25. doi:10.1177/15330338261465062

BibTeX
@article{MoralesDuran2026,
  author = {Morales-Duran, Juan Camilo and Osorno-Castillo, Kevin and Díaz, Gloria M},
  title = {Artificial Intelligence for Breast Cancer Molecular Subtype Prediction From Medical Imaging: A Systematic Review of Literature},
  journal = {Technology in Cancer Research & Treatment},
  year = {2026},
  volume = {25},
  doi = {10.1177/15330338261465062}
}
Kostenlos starten →